IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- but not allergen-induced airway neutrophilia Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis Source: Eur Respir J 2003; 21: 925-931 Year: 2003
IL-10 produced by CD4+ T cells is essential for the development of airway hyperresponsiveness via suppression of endogenous IL-12 Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005
Differential gene expression and cytokine production from neutrophils in asthma phenotypes Source: Eur Respir J 2010; 35: 522-531 Year: 2010
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease Source: Eur Respir J 2006 Oct 01;28(4):824-831 Year: 2006
IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
IL-15 transpresentation in circulating progenitors of NK cells controls their differentiation potential, STAT6 activation and IL-13 production Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005
Free, soluble interleukin-17 protein during severe inflammation in human airways Source: Eur Respir J 2002; 19: 534-537 Year: 2002
Endotoxin-induced IL-17 release by murine T-lymphocytes: interactions with airway macrophages Source: Eur Respir J 2001; 18: Suppl. 33, 408s Year: 2001
Rhinovirus induces airway fibroblast release of neutrophil but not eosinophil chemokines Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005
Overproduction of IL-18 in the lungs induces IL-13 and IFN-g producing CD4+ T cell in the lungs, and results in airway hyperresponsiveness in Balb/c mice Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011
Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007
Interferon-β augments eosinophil adhesion-inducing activity of endothelial cells Source: Eur Respir J 2008; 32: 1540-1547 Year: 2008
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002
Theophylline inhibits mobilization of eosinophil induced by interleukin-5 (IL-5) from femoral bone marrow into the blood Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005
TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
Regulatory role of antigen-induced IL-10, produced by Tr1 cells, in airway neutrophilia in a murine model for asthma Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
IL-18, a novel Th1 cytokine, is up-regulated in pulmonary tuberculosis: expression and production by alveolar epithelial cells type II Source: Eur Respir J 2002; 20: Suppl. 38, 213s Year: 2002
Airway inflammation: assessment of neutrophil apoptosis in induced sputum Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005